Reaction

Dyspnoea At Rest reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,858 reports · 106 co-occurring drugs

As of the last recalculation, Dyspnoea At Rest appears in 2,858 FAERS reports alongside 106 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 52.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoprostenol	91	52.3	52.6
Eplerenone	72	42.0	42.2
Selexipag	121	35.6	35.7
Riociguat	139	32.6	32.7
Treprostinil	408	27.5	27.5
Macitentan	218	24.7	24.8
0Xygen	152	23.7	23.8
Oxygen	152	23.7	23.7
Sildenafil	156	20.7	20.7
Torsemide	73	16.4	16.5
Telmisartan	38	15.7	15.7
Ciclesonide	29	15.7	15.7
Tadalafil	198	15.4	15.4
Omalizumab	155	13.9	14.0
Sildenafil Powder,	66	13.8	13.8
Metolazone	21	13.7	13.7
Ambrisentan	213	13.3	13.4
Bisoprolol Fumarate	224	12.9	13.0
Nintedanib	50	11.8	11.8
Sildenafil Citrate	192	11.7	11.7
Quinine	12	10.2	10.2
Ramipril	161	10.0	10.0
Budesonide And Formoterol Fumarate Dihydrate	126	9.8	9.9
Linagliptin	24	9.7	9.7
Esomeprazole Magnesium Capsule, Delayed Release	19	9.6	9.6
Esomeprazole Magnesium Delayed Release Capsules	19	9.6	9.6
Esomeprazole Magnesium Dihydrate	19	9.6	9.6
Bosentan	64	9.4	9.4
Montelukast	105	9.4	9.4
Candesartan Cilexetil	33	9.2	9.2
Clopidogrel Bisulfate	124	9.2	9.2
Desoximetasone	22	8.5	8.5
Montelukast Sodium	133	8.3	8.3
Candesartan	40	8.3	8.3
Tiotropium Bromide	144	8.0	8.0
Fluticasone Furoate	13	7.8	7.9
Ticagrelor	34	7.8	7.9
Spironolactone	144	7.8	7.8
Theophylline Anhydrous	13	7.7	7.7
Mometasone	18	7.2	7.2
Pitavastatin Calcium	10	7.1	7.1
Theophylline	11	7.0	7.0
Valsartan Oral	50	6.8	6.8
Amiodarone Hydrochloride	10	6.5	6.5
Sitagliptin And Metformin Hydrochloride	19	6.5	6.5
Nebivolol	14	6.4	6.4
Mometasone Furoate	36	6.4	6.4
Atorvastatin Calcium, Film Coated	58	6.1	6.1
Tiotropium Bromide Inhalation Spray	9	5.9	5.9
Esomeprazole	48	5.7	5.7
Moxifloxacin	11	5.7	5.7
Brivaracetam	7	5.7	5.7
Albuterol Sulfate	217	5.7	5.7
Pertuzumab	21	5.7	5.7
Isosorbide Dinitrate	15	5.6	5.6
Methimazole	6	5.6	5.6
Bumetanide	20	5.5	5.5
Fluticasone Propionate And Salmeterol Xinafoate	45	5.5	5.5
Paclitaxel (Aibumin-Bound)	60	5.4	5.4
Mepolizumab	36	5.3	5.3
Furosemide	270	5.3	5.3
Cladribine	7	5.3	5.3
Clopidogrel	134	5.1	5.1
Regorafenib	8	5.0	5.0
Ezetimibe	51	5.0	5.0
Tolvaptan	10	5.0	5.0
Insulin Glulisine	7	5.0	5.0
Dronedarone	7	5.0	5.0
Budesonide, Glycopyrrolate, And Formoterol Fumarate	7	4.9	4.9
Ravulizumab	9	4.9	4.9
Carvedilol	87	4.8	4.8
Paclitaxel	61	4.6	4.6
Loratadine Oral	30	4.5	4.5
Doxazosin	17	4.4	4.4
Fulvestrant	20	4.4	4.4
Linezolid	18	4.4	4.4
Dexlansoprazole	25	4.4	4.4
Everolimus Tablets	10	4.4	4.4
Naltrexone Hydrochloride And Bupropion Hydrochloride	5	4.3	4.3
Isosorbide Mononitrate	12	4.2	4.2
Ribociclib	18	4.2	4.2
Pemetrexed	12	4.1	4.1
Trastuzumab	38	4.1	4.1
Azelastine	10	4.1	4.1
Benzonatate	9	4.0	4.0
Sacubitril And Valsartan	61	3.9	3.9
Apixaban	35	3.8	3.8
Iron Sucrose	5	3.8	3.8
Lapatinib	8	3.8	3.8
Lanreotide Acetate	4	3.7	3.7
Fluticasone Furoate And Vilanterol Trifenatate	17	3.5	3.5
Carboplatin	55	3.2	3.2
Pemetrexed Disodium	16	3.1	3.1
Droxidopa	9	3.0	3.0
Pirfenidone	16	2.9	2.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	16	2.8	2.8
Docetaxel Anhydrous	24	2.6	2.6
Docetaxel	24	2.6	2.6
Bimatoprost	10	2.5	2.5
Fam-Trastuzumab Deruxtecan-Nxki	3	2.2	2.2
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.0	2.0
Apalutamide	3	1.9	1.9
Tafamidis	3	1.9	1.9
Rimegepant Sulfate	3	1.7	1.7
Osimertinib	7	1.6	1.6
Dornase Alfa	4	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.